| View |
|
BR-1123
|
Obinutuzumab
|
Gazyva
|
1 g/40 mL (25mg/mL)
|
Concentrate For Solution For Infusion (IV)
|
Prescription Drug (RX)
|
Type I Borosilicate glass vial with fluoro resign stopper and aluminum overseal with plastic flip-off disk x 40mL (Box of 1's)
|
-
|
Roche Diagnostics GmbH
|
Germany
|
N/A
|
Roche (Philippines) Inc.
|
Roche (Philippines) Inc.
|
Initial (Variation)
|
12 August 2022
|
12 August 2027
|
| View |
BR-1125_PI_01.pdf
|
BR-1125
|
Quadrivalent Seasonal Influenza Vaccine (Split Virion,
Inactivated) Southern Hemisphere 2024 Strain.
|
Fluarix Tetra
|
Each dose (0.5 mL) contains the following influenza strains*:
A/Victoria/4897/2022 (H1N1)pdm09-like strain
(A/Victoria/4897/2022, IVR-238)
A/Thailand/8/2022 (H3N2)-like strain
(A/Thailand/8/2022, IVR-237)
B/Austria/1359417/2021-like strain
(B/Austria/1359417/2021, BVR-26)
B/Phuket/3073/2013-like strain
(B/Phuket/3073/2013, wild type) [Yamagata lineage] *Propagated in embryonated chicken eggs
**Haemagglutinin
15 μg of HA**
15 μg of HA**
15 μg of HA**
15 μg of HA**
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
0.5 mL in 1 mL Type I pre-filled glass syringe with luer lock adapter and plastic rigid tip cap (PRTC) and 2 separate needles (25G 5/8" and 25G 1") in a plastic tray (Box of 1's).
|
Vaccines
|
GlaxoSmithKline Biologicals NL Der SmithKline
|
Germany
|
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Monitored Release (Strain Clearance)
|
19 February 2024
|
19 February 2025
|
| View |
|
BR-1126
|
Secukinumab
|
Cosentyx
|
150 mg/mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
1 mL Type I pre-filled glass syringe with grey
bromobutyl rubber plunger stopper, stainless steel 276 12" needle and rubber needle shield, assembled in UltraSafe PassiveTM Needle Guard X100L (Box of l's and 2's)
|
Interleukin Inhibitors
|
Novartis Pharma Stein AG
|
Switzerland
|
N/A
|
Novartis Healthcare Philippines, Inc.
|
Novartis Healthcare Philippines, Inc.
|
Initial (from Monitored Release)
|
12 April 2022
|
06 January 2026
|
| View |
|
BR-1127
|
Secukinumab
|
Scapho
|
150 mg
|
Powder For Solution For Injection (SC)
|
Prescription Drug (RX)
|
6 mL Type I colourless glass vial with grey chlorobutyl rubber stopper and aluminum crimp with white flip-off cap (Box of 1's)
|
Interleukin Inhibitors
|
Novartis Pharma Stein AG, Pharmaceutical
|
Switzerland
|
N/A
|
Sandoz Philippines Corporation
|
Sandoz Philippines Corporation
|
Initial (from Monitored Release)
|
07 April 2022
|
14 January 2026
|
| View |
BR-1130_PI_01.pdf
|
BR-1130
|
Secukinumab
|
Scapho
|
150 mg/mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
1 mL Type I pre-filled glass syringe with grey
bromobutyl rubber plunger stopper, stainless steel 276 12" needle and rubber needle shield, assembled in an autoinjector pen with transparent window (SensoReady pen) (Box of 1's)
|
-
|
Novartis Pharma Stein AG, Pharmaceutical
|
Switzerland
|
|
Novartis Healthcare Philippines, Inc.
|
Novartis Healthcare Philippines, Inc.
|
Initial (from Monitored Release)
|
11 April 2022
|
06 January 2026
|
| View |
|
BR-1133
|
Pneumococcal Conjugate Vaccine, 13-Valent
(adsorbed) [See formulation on reverse side]
|
Prevenar 13
|
0.5 mL
|
Suspension For Injection (IM)
|
Prescription Drug (RX)
|
Single Dose : 0.5 mL suspension for injection in Becton-Dickinson (BD) Hypak® SCFR Luer-Lok® syringes or Schott SyriQ Luer-Lok® Round Flange pre-filled syringe (Type I Glasss) with separate 25G needle in a Box
|
-
|
Pfizer Ireland Pharmaceuticals
|
Ireland
|
|
Pfizer, Inc.
|
Pfizer, Inc.
|
-
|
10 September 2021
|
21 January 2026
|
| View |
|
BR-1135
|
Chorionic Gonadotrophin
|
Chorapur
|
5000 IU
|
Powder for Injection (IM)
|
Prescription Drug (RX)
|
Type I Glass Vial + 1 mL Type I Glass Ampoule (Diluent: 0.9% Sodium chloride) (Box of 3's)
|
-
|
Ferring GmbH
|
Germany
|
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
-
|
08 March 2021
|
09 February 2026
|
| View |
|
BR-1136
|
Bevacizumab
|
Mvasi
|
100 mg/4 mL (25 mg/mL)
|
Concentrate For Solution For Infusion (IV)
|
Prescription Drug (Rx)
|
6 mL USP/EP Type I clear, colorless glass vial with
light gray elastomeric stopper and blue aluminum seal with yellow polypropylene flip-off cap (Box of l's)
|
-
|
Amgen Manufacturing Limited
|
USA
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial
|
28 January 2021
|
28 January 2026
|
| View |
|
BR-1137
|
Filgrastim
|
Neubicyte
|
300mcg/mL
|
Solution for Injection
|
Prescription Drug (RX)
|
Pre-filled Syringe (Box of 1's)
|
Hematopoietic Growth Factor
|
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
|
China
|
|
Endure Medical, Inc.
|
Endure Medical, Inc.
|
Renewal
|
30 March 2021
|
10 February 2026
|
| View |
|
BR-1138
|
Pembrolizumab
|
Keytruda
|
100mg/4mL (25mg/mL
|
Solution For Injection (IV Infusion)
|
Prescription Drug (RX)
|
In a box of one 10mL Type I glass vial, with a grey chlorobutyl stopper and an aluminum seal with a dark blue flip-off cap
|
Antineoplastic
|
MSD International GmbH T/A MSD Ireland (Carlow)
|
Ireland
|
N/A
|
Merck Sharp & Dohme (I.A) LLC
|
|
Initial
|
06 July 2021
|
17 February 2026
|
| View |
|
BR-1141
|
Rituximab
|
Mabthera
|
10 mg/ mL
|
Concentrate For Solution For Infusion (IV)
|
Prescription Drug (RX)
|
10 mL and 50 mL USP Type I Colorless Glass Vial (Box of 1's)
|
-
|
Roche Diagnostic GmbH
|
Germany
|
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
08 March 2021
|
24 November 2025
|
| View |
|
BR-1147
|
Pneumococcal Vaccine, Polyvalent
|
Pneumovax 23
|
25mcg/0.5mL
(serotypes: 1,2,3,4,5,6B,7F,8,9N,9V,
10A,11A,12F,14,15B,17F,18C,19F,19A,20,22F,23F,33F
dissolved in isotonic saline soln containing 0.25%
phenol as preservative)
|
Solution For Injection (S.C./I.M.)
|
Prescription Drug (RX)
|
0.5 mL Type I Glass Pre-filled Syringe (Box of 1's)
|
-
|
Merck Sharp & Dohme Corp.
|
USA
|
N/A
|
Merck Sharp & Dohme (I.A.) LLC
|
N/A
|
-
|
19 April 2021
|
11 April 2026
|
| View |
|
BR-1148
|
Combined Diphtheria, Tetanus, Acellular Pertussis Vaccine, Adsorbed
|
Boostrix
|
Formulation: 1 dose (0.5 mL) contains:
Diphtheria toxoid*-Not less than 2 IU (2.5Lf) Tetanus toxoid*-Not less than 20 IU (5Lf) Pertussis toxoid (PT)*-8mcg Filamentous Hemagglutinin (FHA)*-8mcg Pertactin-2.5mcg *adsorbed on Aluminum hydroxide, hydrated (Al(OH)3)-300 mcg Al3 and Aluminum phosphate (AlPO4)-200 mcg A13+
|
Suspension For Injection (I.M.)
|
Prescription Drug (RX)
|
0.5 mL Suspension in Type I Glass Vial with Gray Butyl Rubber Stopper and Flip-off Cap (Box of 10's)
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
N/A
|
Renewal
|
27 April 2021
|
03 June 2026
|
| View |
|
BR-1152
|
Siltuximab
|
Sylvant
|
100 mg
|
Powder For Concentrate For Solution For Infusion
|
Prescription Drug (RX)
|
8 mL Type I clear glass vial closed with a
fluoropolymer coated 20 mm lyophilization-type stopper and a 20 mm aluminum seal with a flip-off button (Box of l's)
|
-
|
Cilag AG
|
Switzerland
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial
|
19 October 2021
|
04 August 2026
|
| View |
|
BR-1153
|
Siltuximab
|
Sylvant
|
400 mg
|
Powder For Concentrate For Solution For Infusion
|
Prescription Drug (RX)
|
30 mL Type I clear glass vial closed with a
fluoropolymer coated 20 mm lyophilization-type stopper and a 20 mm aluminum seal with a flip-off button (Box of l's)
|
-
|
Cilag AG
|
Switzerland
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial
|
16 November 2021
|
04 August 2026
|
| View |
|
BR-1154
|
Insulin Glargine
|
Basagine
|
100 Units/mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
1-PVC Tray containing 3 mL Solution in 5 mL USP Type I Clear Glass Vial with Cream Color Rubber Stopper and Aluminum Seal with Purple Color Flip-off Cap (Box of 1's)
|
Insulins and Analogues
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
|
Getz Pharma Phils., Inc.
|
|
Renewal
|
27 April 2021
|
03 June 2026
|
| View |
|
BR-1155
|
Human Normal Immunoglobulin
|
Octagam 10%
|
100mg/mL (10% w/v)
|
Solution for IV Infusion
|
Prescription Drug (RX)
|
Type II Glass Bottle with Bromobutyl Rubber Stopper
sealed with Aluminum Flip-off Cap (20 mL solution in 30 mL; 50 mL Solution in 70 mL; 100 mL; 200 mL Solution in 250 mL) (Box of 1's)
|
Immunoglobulin
|
Octapharma Pharmazeutika Produktionsges.m.b.H
|
Austria
|
N/A
|
Medlink Marketing
|
Medlink Marketing
|
Renewal
|
25 March 2022
|
07 June 2026
|
| View |
|
BR-1156
|
Human Normal Immunoglobulin
|
Octagam 5%
|
50mg/mL (5% w/v)
|
Solution for IV Infusion
|
Prescription Drug (RX)
|
Type II Glass Bottle with Bromobutyl Rubber Stopper
sealed with Aluminum flip-off cap (20 mL Solution in 30 mL; 50 mL solution in 70 mL; 100 mL; 200 mL Solution in 250 mL) (Box of 1's)
|
-
|
Octapharma Pharmazeutika Produktionsges.m.b.H
|
Austria
|
N/A
|
Medlink Marketing
|
Medlink Marketing
|
-
|
25 March 2022
|
07 June 2026
|
| View |
|
BR-1157
|
Human Albumin
|
Albunorm 25%
|
250 g/L (25% w/v)
|
Solution for IV Infusion
|
Prescription Drug (RX)
|
Type II infusion glass bottle with bromobutyl rubber
stopper x 50 mL and 100 mL (Box of l's)
|
-
|
Octapharma
|
France
|
|
Medlink Marketing
|
Medlink Marketing
|
-
|
20 January 2022
|
06 June 2026
|
| View |
|
BR-1161
|
Insulin Human (rDNA)
|
Scilin M30
|
30% Soluble Insulin + 70% Isophane Insulin 100 IU/mL
|
Suspension For Injection (SC)
|
Prescription Drug (RX)
|
Clear and colorless glass cartridge x 3 mL(Box of 5's)
|
-
|
Bioton S.A.
|
Poland
|
SciGen Ltd.
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
Regular Renewal
|
26 February 2021
|
04 October 2025
|